Unveiling Deception in Pharmaceutical Marketing

This chapter explores the misleading marketing tactics used by a pharmaceutical company in promoting OxyContin, focusing on their selective use of scientific data. It also reveals a significant cover-up where early warnings about the drug's addiction potential were ignored to safeguard their profits.